Pharmacy Daily | Vitura’s new proven hand at the helm

VITURA Health appointed Robert Iervasi (pictured) as Independent Chair and a Non-Executive Director of its Board yesterday, replacing Dr Marcia Walker who had held the position of Interim Chair since Sep last year.

With a background in both corporate governance and consumer products, Iervasi said he is focused on driving profitability and growth with decades of experience as a CFO, General Counsel and CEO through the various executive and Board roles he has held.

These include companies such as Asahi Beverages, HS Fresh Foods Group, Allpress Expresso and Circular Plastics Australia.

Through these roles, Vitura stated Iervasi has a proven ability to identify opportunities, mitigate enterprise-wide risks and implement revenue and cost synergies for the company.

Vitura stated Iervasi will pay special attention to employee engagement, which he believes is integral to the success of an integrated business, and is core business for most boards.

CEO Rodney Cocks said, "Robert brings a wealth of experience to Vitura having recently concluded a distinguished executive career at a global level with Asahi Beverages as Group CEO, which delivered exceptional operational, and financial growth, and the $16 billion acquisition of CUB".

"Joining Vitura at this time represents an exciting opportunity.

"The growth already achieved by Vitura, coupled with Vitura's relentless ambition to enhance the healthcare experience, means that we are well placed to continue to grow and excite our consumers."

Iervasi added he is keen to bring his experience in consumer products and FMCG to Vitura as "we work towards redefining healthcare in our markets".

His remuneration as Chair of Vitura is $120,000 per annum and he will join the Company's Audit and Risk and Nomination and Remuneration Committees.

Vitura stated Walker will remain on the Board as an independent, Non-Executive Director. JG